A5062186890- Epilepsy research and treatment
- Acute Ischemic Stroke Management
- Neonatal and fetal brain pathology
- Cerebral Venous Sinus Thrombosis
- Stroke Rehabilitation and Recovery
- Healthcare Systems and Practices
- Pharmacological Effects and Toxicity Studies
- Parkinson's Disease Mechanisms and Treatments
- Peripheral Neuropathies and Disorders
- Tumors and Oncological Cases
- Agriculture and Rural Development Research
- Intracerebral and Subarachnoid Hemorrhage Research
- Sinusitis and nasal conditions
- Blood Coagulation and Thrombosis Mechanisms
- Infectious Encephalopathies and Encephalitis
- Oral and Maxillofacial Pathology
- Cerebral Palsy and Movement Disorders
- Myasthenia Gravis and Thymoma
- Infectious Diseases and Tuberculosis
- Tuberculosis Research and Epidemiology
- Neuroscience and Neuropharmacology Research
- Head and Neck Surgical Oncology
- Antifungal resistance and susceptibility
- Parasite Biology and Host Interactions
- Botulinum Toxin and Related Neurological Disorders
Cheikh Anta Diop University
2015-2024
Centre Hospitalier National Universitaire de Fann
2015-2024
Hôpital Principal de Dakar
1996-2023
Instituto de Investigación Sanitaria del Hospital Clínico San Carlos
2023
Hôpital Aristide Le Dantec
2013-2023
Sonatel (Senegal)
2023
Institut Pasteur de Dakar
2022
Hôpital d'Enfants
2018-2022
Université de Thiès
2020-2021
CHU Dijon Bourgogne
2021
<h3>Objective</h3> The impetus for this consensus discussion was to recommend clinical trial designs that can deliver high-quality data effective therapies pediatric patients, in a reasonable timeframe, with key focus on short- and long-term safety. <h3>Methods</h3> International Pediatric Multiple Sclerosis Study Group convened meeting of experts review the advances understanding pediatric-onset multiple sclerosis (MS) advent trials population. <h3>Results</h3> In last few years, convincing...
BackgroundIntegrase inhibitor (INSTI) with boosted darunavir (DRV/r), a regimen high-resistance barrier, avoiding NRTI toxicities, might be switching option in children living HIV (CLWHIV).MethodsSMILE is randomised non-inferiority trial evaluating safety and antiviral efficacy of once-daily INSTI + DRV/r vs. continuing on current standard-of-care (SOC) triple ART (2NRTI PI/NNRTI) virologically-suppressed CLWHIV aged 6–18 years. The primary outcome the proportion confirmed HIV-RNA ≥50...
Introduction: Medical studies are unique in that they both theoretical and practical. The main objective was to evaluate the psychological experience quality of night-time sleep medical science students during their clinical placements. Methodology: We conducted a cross-sectional, descriptive, analytic study 7th-year at El Hadj Ibrahima Niasse University. It took place from November 11, 2023, March 21, 2024. Data were collected using questionnaire based on Google Forms. Results: A total 108...
Introduction : La Fièvre Hémorragique de Crimée-Congo (FHCC) est une maladie virale sévère causée par un virus du genre Nairovirus, principalement transmise les tiques et, dans certains cas, contact avec sang ou des fluides corporels infectés. FHCC endémique plusieurs régions d’Afrique. Cette étude se concentre sur cas au Sénégal en 2023 et réponses déployées pour gérer l’épidémie. Méthodologie Une rétrospective a été réalisée analyser l’épidémie 2023. Le Réseau Surveillance Sentinelle...
The extent of neuromeningeal cryptococcosis (NMC) has increased since the advent HIV/AIDS. It non-specific clinical signs but marked by high mortality.To analyze characteristics NMC in sub-Saharan Africa.We have conducted a literature reviewed on Africa from publications available basis national and international data with keywords such as "Cryptococcus, Epidemiology, Symptoms, Outcomes Mortality" their equivalent French July 2011. All 1990 to 2010 202 references were analyzed. following...
With the aging of population, dementia is increasing worldwide. The objective this study was to identify risk factors for in an elderly population utilizing a primary health care service Dakar, Senegal.Through cross-sectional conducted from March 2004 December 31, 2005, 507 patients aged ≥65 years who came Social and Medical Center IPRES, Senegal, were first screened with screening interview questionnaire 'Aging Senegal'. Those cognitively impaired underwent clinical examination detect...